News and Trends 14 Jul 2022
GenScript ProBio enters strategic partnerships with two South Korean biotechs
GenScript ProBio, the CDMO segment of the leading biotech GenScript, has entered into a strategic partnership memorandum of understanding (MOU) with DAAN Bio Therapeutics for the discovery and development of novel drugs and with ACT Therapeutics to develop new CAR-T cell therapies. With offices located in the U.S., the Netherlands, China, Singapore and Japan, GenScript […]